Transcutaneous Neurostimulators Market Industry Examined In New Market Research Report

Press Release

Neurostimulation is the process of stimulation of nervous tissues by low electric impulses. These electric impulses block the transmission of pain messages to the brain. Patients may feel a minor tickling sensation instead of pain.

View Report:

Neurostimulation is generally considered an electromagnetic approach toward neuromodulation. Advanced technologies of neurostimulation can improve the quality of life of patients suffering from deep harms to their different sense organs or patients severely paralyzed. It can lead to long-lasting fall of chronic, severe pain (such as spinal cord injury and neuropathic pain) that would otherwise require high-dose analgesic drugs or opioid therapy. Neurostimulation works as the crucial part of neural prosthetics for brain–machine interfaces, artificial limbs, artificial vision, and hearing aids.

In the case of nerve stimulation, typically electrical stimulation methods are used. Other than this method also charge-balanced biphasic continuous current waveforms or capacitive attached charge injection methods are widely used. Otherwise, transcranial electric stimulation and transcranial magnetic stimulation have been suggested as non-invasive techniques, in which either transcranially applied electric currents or a magnetic field causes neurostimulation. There exist various stimulation processes for the treatment of different kinds of critical diseases such as epilepsy, Parkinson’s disease, tremors, and dystonia. Brain stimulation is capable to cure certain disorders such as epilepsy. In this technique, planned stimulation is employed on specific subcortical or cortical targets.

Request a Brochure of the Report @

There exist marketable devices that can transport an electric impulse in the scheduled time duration, and this scheduled stimulation is assumed to modify the fundamental neurophysiologic characters of epileptic networks. Key targets for the scheduled stimulation are anterior nucleus of the hippocampus and the thalamus. The global market for transcutaneous neurostimulators is expanding significantly, due to increase in use of transcranial magnetic stimulation (TMS) and transcutaneous electric nerve stimulation (TENS) and rise in the number of patients. Procedure size development for nerve stimulation is considerably high in countries such as Mexico, China, India, and Brazil; owing to factors such as high prevalence of diseases, rapid progression of the disease, widening insurance coverage, economic growth, improving health care infrastructure, expanding private health care sector, and rising awareness among people in these countries.

As per the International Neurostimulation Society, around 40 to 50 million patients are suffering from epilepsy worldwide and 1.5 million patients from Parkinson’s disease in the U.S. alone. The large number of patients suffering from different diseases such as tremors, urinary incontinence, lower back pain, anxiety, stroke, and depression is also a prominent factor boosting the market. Treatment of tinnitus denotes an emergent use of transcutaneous neurostimulators. As per the American Tinnitus Association, around 50 million people are suffering from tinnitus in the U.S. alone. Major drivers for the transcutaneous neurostimulators market are high incidence of chronic disorders, increase in elderly population, cost-effectiveness of transcutaneous neurostimulators, wide range of their usage, and rise in the demand for non-invasive therapy. However, less advanced technologies, less effective results of transcutaneous neurostimulators, and proofs that these devices give improved results when used with other non-invasive or minimally invasive neuromodulation devices are major restraints for the market.

The global transcutaneous neurostimulators market can be segmented by product, application, and geography. Based on product, the market has been broadly categorized into sacral nerves, vagus nerves, brain, and others. Based on application, the market has been segmented into Alzheimer’s disease, gastroparesis, incontinence, Parkinson’s disease, and others. Based on geography, the global transcutaneous neurostimulators market has been divided into North America, Latin America, Europe, Asia Pacific, and Rest of World.

Request TOC @

Major players operating in the global transcutaneous neurostimulators market are Medtronic, Neurotech SA (a Sorin Group Company), Zynex Medical, Inc., Cyberonics, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Enteromedics, Inc., Dynatronics Corp., and Neuronetics.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]



Related Articles